Unidox Solutab, 10 pcs., 100 mg, dispersible tablets

Nosological classification (ICD-10)

• A49.3 Mycoplasma infection, unspecified
• A53.9 Syphilis, unspecified
• A54 Gonococcal infection
• A55 Chlamydial lymphogranuloma (venereal)
• A69.2 Lyme disease
• A70 Chlamydia psittaci infection
• A75 Typhus
• H60 Otitis externa
• H66 Suppurative and unspecified otitis media
• H70 Mastoiditis and related conditions
• J01 Acute sinusitis
• J02.9 Acute pharyngitis, unspecified
• J03.9 Acute tonsillitis, unspecified (angina agranulocytic)
• J04 Acute laryngitis and tracheitis
• J06 Acute upper respiratory tract infections of multiple and unspecified localization
• J22 Acute respiratory infection of the lower respiratory tract, unspecified
• J31 Chronic rhinitis, nasopharyngitis and pharyngitis
• J32 Chronic sinusitis
• J35.0 Chronic tonsillitis
• J37 Chronic laryngitis and laryngotracheitis
• K62.8.1* Proctitis
• L08.9 Local infection of skin and subcutaneous tissue, unspecified
• L70 Acne
• M60.0 Infectious myositis
• M65 Synovitis and tenosynovitis
• M65.0 Tendon sheath abscess
• M71.0 Abscess of bursa
• M71.1 Other infectious bursitis
• M86 Osteomyelitis
• N30 Cystitis
• N34 Urethritis and urethral syndrome
• N39.0 Urinary tract infection without established location
• N41 Inflammatory diseases of the prostate gland
• N49 Inflammatory diseases of the male genital organs, not elsewhere classified
• N71 Inflammatory diseases of the uterus, except the cervix
• N73.9 Inflammatory diseases of the female pelvic organs, unspecified
• N74.2 Inflammatory diseases of the female pelvic organs caused by syphilis (A51.4+, A52.7+)
• N74.3 Gonococcal inflammatory diseases of the female pelvic organs (A54.2+)

Unidox Solutab price, where to buy

The average price of tablets in Russia is about 300 rubles. per pack 10 pcs.

• Online pharmacies in RussiaRussia
• Online pharmacies in UkraineUkraine
• Online pharmacies in KazakhstanKazakhstan

ZdravCity

• Unidox Solutab dispersible tablets 100 mg 10 pcs. ZiO-Zdorovye ZAO
  314 rub. order
• Unidox solutab dispersant tablets. 100 mg 20 pcs. ZiO-Zdorovye ZAO

  RUB 593 order

Pharmacy Dialogue

• Unidox Solutab (table dispersant 100 mg No. 10) ZiO-Zdorovye CJSC/Astellas Pharma Europe B.V.

  RUB 327 order

• Unidox Solutab (table dispersant 100 mg No. 20)Astellas Pharma/ZiO-Zdorovye CJSC

  RUR 624 order

• Unidox Solutab (table dispersant 100 mg No. 10) ZiO-Zdorovye CJSC/Astellas Pharma Europe B.V.

  RUB 314 order

  Read also:  Salmonellosis Sources of infection and how infection occurs
• Unidox Solutab (table dispersant 100 mg No. 20)Astellas Pharma/ZiO-Zdorovye CJSC

  RUR 607 order

show more

Pharmacy24

• Unidox Solutab 100 mg N10 tablets Astellas Pharma Europe B.V., Netherlands
  141 UAH.order

PaniPharmacy

• Unidox solutab tablets Unidox salutab tablets. 100 mg No. 10 Netherlands, Astellas Pharma Europe

  152 UAH order

show more

Pharmacodynamics

Broad-spectrum antibiotic from the tetracycline group. It acts bacteriostatically, suppresses protein synthesis in the microbial cell by interacting with the 30S ribosomal subunit. Active against many gram-positive and gram-negative microorganisms: Streptococcus spp., Treponema spp., Staphylococcus spp., Klebsiella spp., Enterobacter spp. (including E. aerugenes), Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum, Listeria monocytogenes, Rickettsia spp., Typhus exanthematicus, Escherichia coli, Shigella spp., Campylobacter fetus, Vibrio cholerae, Yersinia spp. (including Yersinia pestis), Brucella spp., Francisella tularensis, Bacillus anthracis, Bartonella bacilliformis, Pasteurella multocida, Borrelia recurrentis, Clostridium spp. (except Clostridium difficile), Actinomyces spp., Fusobacterium fusiforme, Calymmatobacterium granulomatis, Propionibacterium acnes, some protozoa (Entamoeba spp., Plasmodium falciparum).

As a rule, it has no effect on Acinetobacter spp., Proteus spp., Pseudomonas spp., Serratia spp., Providencia spp., Enterococcus spp.

The possibility of acquired resistance to doxycycline in a number of pathogens, which is often cross-linked within a group, should be taken into account (i.e., strains resistant to doxycycline will simultaneously be resistant to the entire group of tetracyclines).

Pharmacokinetics

Suction

Absorption is fast and high (about 100%). Food intake has little effect on the absorption of the drug.

Cmax of doxycycline in blood plasma (2.6–3 μg/ml) is achieved 2 hours after taking 200 mg; after 24 hours, the concentration of the active substance in blood plasma decreases to 1.5 μg/ml.

After taking 200 mg on the first day of treatment and 100 mg/day on subsequent days, the plasma concentration of doxycycline is 1.5–3 mcg/ml.

Distribution

Doxycycline binds reversibly to plasma proteins (80–90%), penetrates well into organs and tissues, poorly into the cerebrospinal fluid (10–20% of plasma levels), however, the concentration of doxycycline in the cerebrospinal fluid increases with inflammation spinal membrane.

Volume of distribution - 1.58 l/kg. 30–45 minutes after oral administration, doxycycline is found in therapeutic concentrations in the liver, kidneys, lungs, spleen, bones, teeth, prostate gland, eye tissue, pleural and ascitic fluids, bile, synovial exudate, exudate of the maxillary and frontal sinuses, in gingival sulcus fluids.

With normal liver function, the level of the drug in bile is 5–10 times higher than in plasma.

In saliva, 5–27% of the concentration of doxycycline in blood plasma is determined.

Doxycycline crosses the placental barrier and is secreted into breast milk in small quantities.

Accumulates in dentin and bone tissue.

Metabolism

A small portion of doxycycline is metabolized.

Removal

T1/2 after a single oral dose is 16-18 hours, after repeated doses - 22-23 hours.

Approximately 40% of the drug taken is excreted by the kidneys and 20–40% is excreted through the intestines in the form of inactive forms (chelates).

Pharmacokinetics in special clinical situations

The half-life of the drug in patients with impaired renal function does not change, because its excretion through the intestines increases.

Hemodialysis and peritoneal dialysis do not affect the concentration of doxycycline in blood plasma.

Analogues of Unidox Solutab

Level 4 ATC code matches:
Vibramycin

Doxycycline hydrochloride

Doxycycline

The most common analogues:

• Doxycycline
• Vidoccin
• Vibramycin
• Doxibene
• Doxa-M-Ratiopharm
• Tigacil

The price of analogues differs significantly from the original, most often it is lower.

Doxycycline or Unidox Solutab - which is better?

The main difference between the drugs is the fact that Unidox does not have such a strong effect on the stomach and does not cause side effects characteristic of Doxycycline ( stomach ulcer , gastritis ). Absorption of the active substance occurs in the intestines and almost 100% of the medicine is absorbed by the body. The only advantage of doxycycline is its extremely low cost compared to the original.

What is the difference between Unidox and Unidox Solutab?

The prefix “Solyutab” in the name of the drug means that the tablet can be crushed and dissolved in water to prepare a suspension for administration. This method of taking the medicine is preferable for children.

Indications of the drug Unidox Solutab®

Infectious and inflammatory diseases caused by microorganisms sensitive to the drug:

respiratory tract infections, incl. pharyngitis, acute bronchitis, exacerbation of COPD, tracheitis, bronchopneumonia, lobar pneumonia, community-acquired pneumonia, lung abscess, pleural empyema;

infections of ENT organs, incl. otitis media, sinusitis, tonsillitis;

infections of the genitourinary system (cystitis, pyelonephritis, bacterial prostatitis, urethritis, urethrocystitis, urogenital mycoplasmosis, acute orchiepididymitis; endometritis, endocervicitis and salpingoophoritis as part of combination therapy), incl. sexually transmitted infections (urogenital chlamydia, syphilis in patients with penicillin intolerance, uncomplicated gonorrhea (as an alternative therapy), granuloma inguinale, lymphogranuloma venereum);

infections of the gastrointestinal tract and biliary tract (cholera, yersiniosis, cholecystitis, cholangitis, gastroenterocolitis, bacillary and amoebic dysentery, travelers' diarrhea);

infections of the skin and soft tissues (including wound infections after animal bites), severe acne (as part of combination therapy);

other diseases (yaws, legionellosis, chlamydia of various localizations (including prostatitis and proctitis), rickettsiosis, Q fever, Rocky Mountain spotted fever, typhus (including typhus, tick-borne relapsing), Lyme disease (I stage. - erythema migrans), tularemia, plague, actinomycosis, malaria; infectious diseases of the eyes (as part of combination therapy - trachoma); leptospirosis, psittacosis, ornithosis, anthrax (including pulmonary form), bartonellosis, granulocytic ehrlichiosis; whooping cough, brucellosis, osteomyelitis; sepsis, subacute septic endocarditis, peritonitis);

prevention of postoperative purulent complications;

prevention of malaria caused by Plasmodium falciparum during short-term travel (less than 4 months) to areas where strains resistant to chloroquine and/or pyrimethamine-sulfadoxine are common.

Side effects

From the gastrointestinal tract: anorexia, nausea, vomiting, dysphagia, diarrhea; enterocolitis, pseudomembranous colitis.

Dermatological and allergic reactions: urticaria, photosensitivity, angioedema, anaphylactic reactions, exacerbation of systemic lupus erythematosus, maculopapular and erythematous rash, pericarditis, exfoliative dermatitis.

From the liver: liver damage during long-term use or in patients with renal or hepatic insufficiency.

From the kidneys: an increase in residual urea nitrogen (due to the anti-anabolic effect).

From the hematopoietic system: hemolytic anemia, thrombocytopenia, neutropenia, eosinophilia, decreased prothrombin activity.

From the nervous system: benign increase in intracranial pressure (anorexia, vomiting, headache, papilledema), vestibular disorders (dizziness or instability).

On the thyroid gland: in patients receiving doxycycline for a long time, reversible dark brown discoloration of the thyroid tissue is possible.

From the side of teeth and bones: doxycycline slows down osteogenesis, disrupts the normal development of teeth in children (the color of teeth irreversibly changes, enamel hypoplasia develops).

Other: candidiasis (stomatitis, glossitis, proctitis, vaginitis) as a manifestation of superinfection.

Reviews about Unidox Solutab

Reviews in gynecology. The drug has good reviews in the treatment of gynecological diseases, for example chlamydia . Patients who were prescribed the drug for chlamydia note that the antibiotic is easily tolerated and effective. Although sometimes side effects occur in the form of headaches and disruption of the digestive system.

Reviews for use against ureaplasma are also good, many are of the opinion that the drug is almost the only effective way to get rid of the disease.

Reviews of Unidox Solutab for acne. a dermatologist may prescribe antibiotics to treat acne For most patients, acne medication helps, but then other problems arise due to the medication's side effects. For many, following a therapeutic diet helped better than those taking an antibiotic.

Interaction

Antacids containing aluminum, magnesium, calcium, iron preparations, sodium bicarbonate, magnesium-containing laxatives reduce the absorption of doxycycline, so their use should be separated by an interval of 3 hours.

Due to the suppression of intestinal microflora by doxycycline, the prothrombin index decreases, which requires dose adjustment of indirect anticoagulants.

When doxycycline is combined with bactericidal antibiotics that interfere with cell wall synthesis (penicillins, cephalosporins), the effectiveness of the latter is reduced.

Doxycycline reduces the reliability of contraception and increases the frequency of acyclic bleeding when taking estrogen-containing hormonal contraceptives.

Ethanol, barbiturates, rifampicin, carbamazepine, phenytoin and other stimulants of microsomal oxidation, accelerating the metabolism of doxycycline, reduce its concentration in the blood plasma.

The simultaneous use of doxycycline and retinol increases intracranial pressure.

Release form, composition and packaging

Dispersible tablets
are round, biconvex, from light yellow to gray-yellow in color, with a score on one side and engraving “173” (tablet code) on the other.

Excipients:

microcrystalline cellulose, saccharin, hyprolose (low-substituted), hypromellose, colloidal silicon dioxide (anhydrous), magnesium stearate, lactose monohydrate.

10 pieces. - blisters (1) - cardboard packs.

Directions for use and doses

Inside, during meals, the tablet can be swallowed whole, divided into parts or chewed, washed down with a glass of water, or diluted in a small amount of water (about 20 ml).

Typically the duration of treatment is 5–10 days.

Adults and children over 8 years of age weighing more than 50 kg - 200 mg in 1-2 doses on the first day of treatment, then 100 mg daily. In cases of severe infections - at a dose of 200 mg daily throughout treatment.

For children 8–12 years old weighing less than 50 kg, the average daily dose is 4 mg/kg on the first day, then 2 mg/kg per day (in 1–2 doses). In cases of severe infections - at a dose of 4 mg/kg daily throughout treatment.

Features of dosing for certain diseases

For infection caused by S.pyogenes, Unidox Solutab ® is taken for at least 10 days.

For uncomplicated gonorrhea (except for anorectal infections in men): adults - 100 mg 2 times a day until complete cure (on average within 7 days), or 600 mg - 300 mg in 2 doses are prescribed for one day (second taken 1 hour after the first).

For primary syphilis - 100 mg 2 times a day for 14 days, for secondary syphilis - 100 mg 2 times a day for 28 days.

For uncomplicated urogenital infections caused by Chlamydia trachomatis, cervicitis, non-gonococcal urethritis caused by Ureaplasma urealyticum - 100 mg 2 times a day for 7 days.

For acne - 100 mg/day; course of treatment - 6–12 weeks.

Malaria (prevention) - 100 mg 1 time per day 1–2 days before the trip, then daily during the trip and for 4 weeks after returning; children over 8 years old - 2 mg/kg 1 time per day.

Travelers' diarrhea (prevention) - 200 mg on the first day of the trip in 1 or 2 doses, then 100 mg 1 time per day during the entire stay in the region (no more than 3 weeks).

Treatment of leptospirosis - 100 mg orally 2 times a day for 7 days; prevention of leptospirosis - 200 mg once a week during your stay in a disadvantaged area and 200 mg at the end of the trip.

To prevent infections during medical abortion - 100 mg 1 hour before and 200 mg after the intervention.

Maximum daily doses for adults are up to 300 mg/day or up to 600 mg/day for 5 days for severe gonococcal infections. For children over 8 years old weighing more than 50 kg - up to 200 mg, for children 8-12 years old weighing less than 50 kg - 4 mg/kg daily throughout treatment.

In the presence of renal (Cl creatinine <60 ml/min) and/or liver failure, a reduction in the daily dose of doxycycline is required, since it gradually accumulates in the body (risk of hepatotoxicity).

Form of the medicinal product

The antimicrobial agent Unidox Solutab contains the active substance - doxycycline monohydrate. The release form of the drug is tablets. Various substances are additionally used for their production. Their list is given in the instructions for use of the drug.

Biconvex tablets have certain external signs that can be used to exclude counterfeit. They have a grayish-yellow or brownish tint. Blotches are visible on their surface. In addition, there is an engraving “173” and a risk on different sides. Tablets are packaged in blisters of 10 pieces.

special instructions

There is a possibility of cross-resistance and hypersensitivity to other tetracycline drugs.

Tetracyclines may increase PT; use of tetracyclines in patients with coagulopathies should be carefully monitored.

The anti-anabolic effect of tetracyclines can lead to an increase in the level of residual urea nitrogen in the blood. As a rule, this is not significant for patients with normal renal function. However, in patients with renal failure, an increase in azotemia may occur. The use of tetracyclines in patients with impaired renal function requires medical supervision.

With long-term use of the drug, periodic monitoring of laboratory blood parameters, liver and kidney function is required.

Due to the possible development of photodermatitis, it is necessary to limit exposure to insolation during treatment and for 4–5 days after it.

Long-term use of the drug can cause dysbacteriosis and, as a result, the development of hypovitaminosis (especially B vitamins).

To prevent dyspeptic symptoms, it is recommended to take the drug with meals.

The specific effects on the ability to drive a car and operate machinery have not been studied.